NCT02520219 2015-08-11Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical StudyNanjing NingQi Medicine Science and Technology Co., Ltd.Phase 2 Unknown60 enrolled